奥维斯
ShopShop

Mechanism Deep Dive · CNS Diseases

How the nasal spray platform crosses the BBB to reshape CNS immune environments

This category currently covers Parkinson's disease and Alzheimer's disease. Their commonality lies less in symptoms than in chronic inflammatory amplification, impaired clearance, and insufficient trophic support within the brain, making them fit a shared framework of CNS immune-microenvironment reprogramming.
Nasal BBB Crossing
Delivery route designed to improve CNS targeting efficiency
Microglial De-noising
Reduces abnormally amplified neuroinflammatory loops
Aβ / Tau Clearance
Mechanistic logic for reducing pathological protein burden in AD
Mitochondrial & Synaptic Support
Preserves a repair window for neuronal survival and plasticity
Research positioning: This CNS page is not framed as a simplistic slogan that nasal spray directly cures brain disease. Instead, it presents a more disciplined logic chain: first achieve trans-mucosal and BBB-crossing delivery, then reprogram the CNS immune microenvironment across microglial regulation, pathological protein clearance, and neurotrophic support.

Four Core Mechanistic Tracks

Complete mechanism map for CNS diseases

These four tracks abstract PD and AD into four CNS repair tasks: access, inflammatory de-noising, pathological clearance, and neurotrophic support.

01

Delivery Access

Central Nervous System Diseases

Using the nasal route to cross mucosa and improve BBB access efficiency

The significance of the nasal route is that it offers a delivery entry point closer to the nervous system than conventional peripheral administration. In this context, synthetic biology exosomes act not only as cargo carriers but as engineered vehicles that improve both trans-mucosal uptake and BBB transit efficiency.

Nasal entryTrans-mucosalBBB crossingCNS targeting
02

PD: Neuroinflammation De-noising

Parkinson's Disease (PD)

Suppressing overactive microglia to rebuild a quieter repair environment

Chronically amplified neuroinflammation accelerates loss of already vulnerable neurons. The platform aims to de-noise overactive microglia through signaling reprogramming, reducing inflammatory amplification and secondary injury while also supporting mitochondrial function and blocking apoptotic pathways.

Microglial de-noisingLower neuroinflammationMitochondrial protectionApoptosis blockade
03

AD: Pathological Protein Clearance

Alzheimer's Disease (AD)

Restoring protective microglial function and enhancing Aβ / Tau clearance

The issue is not only that deposits exist, but that the immune network has lost efficient clearance capacity. Through Super-T-based signaling reprogramming, the goal is to move microglia away from inefficient, exhausted, pro-inflammatory states and back toward a more protective functional mode with stronger handling of Aβ and Tau pathology.

Microglial reprogrammingAβ clearanceTau clearanceLower deposition burden
04

Neurotrophic Support

Parkinson's Disease (PD) / Alzheimer's Disease (AD)

Providing external support signals for synaptic and neuronal repair

CNS repair depends not only on clearing inflammation and debris but also on neurotrophic support, synaptic remodeling, and plasticity support. The platform therefore includes exogenous neurotrophic support as a third-layer task, aiming to preserve more recoverable connectivity rather than leave the CNS trapped in a chronically wasting state.

Neurotrophic supportSynaptic repairPlasticity supportCognitive / motor support

Category Summary

Unified platform logic across CNS diseases

This page groups PD and AD together to emphasize BBB-crossing delivery and immune-microenvironment reprogramming rather than present them as two unrelated isolated diseases.

The core logic across the CNS category is to use the nasal route plus synthetic biology exosomes for more efficient CNS access, then apply engineered signaling modules to do three things: suppress amplification of neuroinflammation, restore protective function in dysregulated immune cells, and add neurotrophic plus synaptic-repair support. Rather than claiming a single disease-specific magic pathway, the platform is framed as a reusable architecture for rebuilding CNS immune thresholds across neurodegenerative conditions.
Back to Nasal Spray Research

Continue

Explore pollen allergy, respiratory, or cardiopulmonary-axis mechanisms

All four entries map to the same underlying platform, with different barrier-crossing paths, lesion-homing strategies, and cargo roles configured for each organ system.

Pollen AllergyCardiopulmonary-Axis Diseases